(Total Views: 302)
Posted On: 04/16/2020 5:10:49 PM
Post# of 716
US Patient is given Israeli Pluristem treatment in New Jersey. Treatment stated to thus far have a 100% survival rate.
https://unitedwithisrael.org/israeli-coronavi...US+Patient
Quote:
Just days after Israeli-based Pluristem released preliminary data showing that six critically ill coronavirus patients in the Jewish state who are considered high-risk received the Haifa-based company’s placental cell-therapy treatment and survived one week later, an American COVID-19 patient receive the treatment, which so far has a 100 percent survival rate.
The patient, whose condition was similar to the Israeli ones, was treated with Pluristem’s PLX cell therapy under Israel’s compassionate-use program. He received the treatment at Holy Name Medical Center in New Jersey, where the company is conducting a Phase III critical limb ischemia study......
https://unitedwithisrael.org/israeli-coronavi...US+Patient
(2)
(0)
